Skip to main content
Erschienen in: Journal of General Internal Medicine 10/2019

14.08.2019 | Capsule Commentary

Capsule Commentary on Baumgartner et al., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: a Large Retrospective Cohort Study

verfasst von: Gregory J. Misky, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Excerpt

Baumgartner et al. examined the prophylactic practices of elective primary hip and knee arthroplasties over 2 years, comparing aspirin with other pharmacologic agents in preventing venous thromboembolism (VTE).1 As might be expected, based upon the most recent American College of Chest Physician (ACCP) guidelines that includes aspirin (ASA) as an acceptable pharmacologic alternative in VTE prophylaxis, use of aspirin in this patient population has increased over time.2 And despite this increase in postoperative joint patients receiving aspirin only (vs. other agents), no increase in clinically significant venous thromboembolism was identified out to 90 days. …
Literatur
1.
Zurück zum Zitat Baumgartner C, Maselli J, Auerbach A, Fang M. Aspirin Compared to Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: A Large Retrospective Cohort Study. J Gen Intern Med 5122 Baumgartner C, Maselli J, Auerbach A, Fang M. Aspirin Compared to Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: A Large Retrospective Cohort Study. J Gen Intern Med 5122
2.
Zurück zum Zitat Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e278S–325SCrossRef Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e278S–325SCrossRef
3.
Zurück zum Zitat Chu J, Maselli J, Auerbach A, Fang M. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res 155: 65–72. 2017CrossRef Chu J, Maselli J, Auerbach A, Fang M. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res 155: 65–72. 2017CrossRef
4.
Zurück zum Zitat Vincent V.G. et al. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplast 31: 2608–2616. 2017 Vincent V.G. et al. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplast 31: 2608–2616. 2017
5.
Zurück zum Zitat Anderson D.R. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip of Knee Arthroplasty. N Engl J Med 378:8. 2018 Anderson D.R. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip of Knee Arthroplasty. N Engl J Med 378:8. 2018
Metadaten
Titel
Capsule Commentary on Baumgartner et al., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism after Knee or Hip Arthroplasty: a Large Retrospective Cohort Study
verfasst von
Gregory J. Misky, MD
Publikationsdatum
14.08.2019
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 10/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05170-9

Weitere Artikel der Ausgabe 10/2019

Journal of General Internal Medicine 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.